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Compressibility of tableting materials and properties of tablets 
with glyceryl behenate
The paper studies the compressibility of directly compress-
ible tableting materials with dry binders, spray-dried lac-
tose and microcrystalline cellulose, and glyceryl dibehe nate 
at various concentrations. Compressibility was evaluated 
by means of the energy profile of compression and tensile 
strength of tablets. Release rate of the active ingredient, 
salicylic acid, from the tablets was also examined. In the 
case of microcrystalline cellulose, a higher concentration of 
glyceryl dibehenate increased the strength of tablets, while 
this did not occur in the case of spray-dried lactose. In-
creasing concentration of glyceryl dibehenate prolonged 
the release of salicylic acid; however, no statistically sig-
nificant difference was found compared to the type of the 
dry binder used.
Keywords: lipophilic matrix tablet, glyceryl dibehenate, sali-
cylic acid, energy profile of compression, tensile strength of 
tablets, dissolution profile
Lipophilic matrix systems have recently become popular due to their cheap and easy 
preparation and chemical inertness. They contain various fat alcohols, waxes and fats, e.g., 
cetyl alcohol, glyceryl dibehenate, and carnauba wax (1, 2). These systems are primarily 
used for prolonged release of very easily water-soluble drugs. When a matrix tablet is 
placed in a dissolution medium, flaws, canals and pores are produced on its surface, 
through which the drug is released from the surface and subsequently also from deeper 
parts of the matrix (3). A frequently employed substance for the preparation of lipophilic 
matrix tablets is glyceryl dibehenate in the form of the brand product Compritol® 888 ATO. 
This substance, at concentrations of 1–3 %, is also used in tablets as a lubricant, while for 
prolonged release a concentration above 10 % is necessary (4). The advantages of matrix 
tablets with glyceryl dibehenate include their possible manufacture by direct compression 
as well as tableting after granulation, high resistance against physiological conditions, pH 
independence of drug release; moreover, the active ingredient is released by diffusion and 
the burst-out effect is minimized (5). The aim of this paper was to study the compressibi-
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of glyceryl dibehenate by means of the energy profi le of the compression process and 
tensile strength of tablets. Release rate of the active ingredient, salicylic acid, from lipo-
philic matrix tablets was also evaluated.
EXPERIMENTAL
Materials
Spray-dried lactose Flowlac® 100 was supplied by Meggle Pharma (Germany), micro-
crystalline cellulose Microcel® MC-102 by Blanver (Brazil). Glyceryl dibehenate Compritol® 
888 ATO was obtained from Ga efossé (France) and sodium stearyl fumarate (Lubri-
pharm® SSF) from SPI Pharma (France). Salicylic acid was from JQC (Huayin) Pharmaceu-
tical Co., Ltd. (China).
Preparation of tableting materials
Altogether, six tableting materials of diff erent composition were prepared and tested 
(Table I). Furthermore, tableting materials of the same composition but without salicylic 
acid were prepared, from which subsequently tablets were compressed and served as 
blind samples for the dissolution test.
Substances were mixed in a mixing cube KB 15S (Erweka GmbH, Germany). The dry 
binder was fi rst mixed with the active ingredient for 5 minutes and then glyceryl dibe-
henate was added for further 5 minutes. The last ingredient added was a lubricant, with 
which the mixture was mixed for 2.5 minutes. The mixing speed was 17 rpm. The total 
mass of prepared tableting materials was 30 g. Mixtures without salicylic acid were mixed 
in the same manner, omi ing the step of salicylic acid addition; their mass was 10 g.
Preparation of tablets and energy evaluation of the compression process
Tablets were compressed using the material testing equipment T1-FRO 50 TH.A1K 
Zwick/Roell (Zwick GmbH&Co, Germany) by means of a special die with a lower and an 













MCC + 10 % C – 64 25 10 1
MCC + 15 % C – 59 25 15 1
MCC + 20 % C – 54 25 20 1
FL + 10 % C 64 – 25 10 1
FL + 15 % C 59 – 25 15 1
FL + 20 % C 54 – 25 20 1
MCC – Microcel® MC-102
C – Compritol® 888 ATO
FL – Flowlac® 100
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upper punch. The rate of compaction was 40 mm min–1, pre-load was 2 N, and the rate of 
pre-load 2 mm s–1. The tablets were of cylindrical shape without facets, with 13-mm dia-
meter and 0.5000 ± 0.0010 g mass. Tableting materials with two dry binders were com-
pressed by diff erent compression forces, because the spray-dried lactose was the least 
compressible. The employed compression forces for tableting materials with microcrystal-
line cellulose were 4, 5, and 6, for the mixtures with spray-dried lactose 12, 14, and 16 kN. 
Ten tablets were compressed at each compression force. The computer program testXpert 
V 9.01 (Zwick GmbH&Co, Germany) simultaneously recorded the energy process of com-
pression by means of the »force-displacement« record and numerically evaluated the en-
ergy balance of compression, i.e., the energy of precompression E1, energy of plastic defor-
mation E2, energy of elastic deformation E3, total energy Emax, which is the sum of all 
energies, and plasticity (6, 7). Tablets for dissolution made from all tableting materials were 
also compressed; the employed compression force for the mixtures of microcrystalline 
cellulose with 10 and 20 % glyceryl dibehenate was 5 kN, for the mixture of microcrystal-
line cellulose and 15 % glyceryl dibehenate 6 kN, for the mixtures of spray-dried lactose 
with 10 and 20 % glyceryl dibehenate 12 kN, for the mixture of spray-dried lactose with 15 
% glyceryl dibehenate 15 kN. These diff erent compression forces were used so that all 
tablets may possess approximately the same tensile strength in the range of 0.78–0.88 MPa. 
The number of tablets compressed for dissolution was six.
Measurement of the tensile strength of tablets
Tensile strength of tablets was measured in 10 tablets no sooner than 24 hours a er 
compression (tablets were stored in plastic tubes). Measurements were performed using a 
Schleuniger apparatus (Dr. Schleuniger Pharmatron AG, Switzerland), which measures 
the diameter and height of tablets with a precision of 0.01 mm and destruction force in N. 
Tensile strength of tablets was subsequently calculated according to the equation (Eq. 1) 
(8):
 P = 2F/(p d h) (1)
where P is tensile strength of the tablet in MPa, F is destruction force in N, d is tablet di-
ameter in mm, h is the tablet height in mm.
Dissolution testing
Release of the active ingredient, salicylic acid, was always tested from 6 tablets from 
each tableting material. Tablets were prepared so that all of them had tensile strength 
within the range from 0.78–0.88 MPa. Dissolution testing was performed using the rotat-
ing basket method according to the European Pharmacopoeia 7 (9) on a dissolution unit Sotax 
AT 7 smart (Sotax AG Basel, Switzerland). The test was carried out under sink conditions. 
Dissolution medium was 900 mL of purifi ed water tempetured to 37 °C. The rotation rate 
of the basket was 100 rpm, and at one-hour intervals samples of 3 mL were withdrawn, and 
then this volume was replaced with pure medium. The content of salicylic acid was deter-
mined spectrophotometrically at 270 nm (spectrophotometer Specord 205, Analytic Jena, 
Germany) and the program WinAspect (Analytic Jena, Germany). Absorbance was mea-
sured vs. a blind sample, which was obtained by dissolution of tablets of the corresponding 
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composition but without salicylic acid. Measurements were repeated fi ve times and sub-
sequently averaged. The amount of released active ingredient was determined by means 
of the calibration curve for salicylic acid.
Mathematical and statistical processing of results
The results for tensile strengths and dissolution of tablets were statistically processed 
by means of the computer programmes Excel and Qcexpert (TriloByte Statistical So ware, 
s.r.o., Czech Republic). The values of energies and plasticity were statistically processed by 
the computer programme testXpert V 9.01 (Zwick GmbH&Co, Germany) during compac-
tion. In the case of similar signifi cance of values, an unpaired t-test at a level of signifi cance 
of 0.05 was employed. Experimental dissolution data were mathematically processed and 
statistically evaluated by means of the computer programs GraphPad Prism (GraphPad 
So ware, Inc., USA) and Origin 9 Pro (OriginLab Corporation, USA). Three mathematical 
models were used for the analysis of dissolution profi les. Coeffi  cient of determination R2 
and residual sum of squares RSS were used for comparison of dissolution profi les.
RESULTS AND DISCUSSION
Compressibility of tableting materials
Compressibility of tableting materials was evaluated by means of the energy profi le 
of the compression process and on the basis of the test of tensile strength of tablets. The 
individual components of energy balance of compression are listed in Table II. Adjustment 
of compression forces was thus controlled by the adjustment of tensile strength of tablets 
within the optimal range of tablet strength, 0.56 – 1.12 MPa (10). Poorer compressibility of 
spray-dried lactose is evident from the values of plasticity (45.0–58.3 %), which are mark-
edly lower than the values for microcrystalline cellulose (81.7–87.9 %). Excellent plastic 
deformability, which is also the compression mechanism of microcrystalline cellulose, is 
generally known, in contrast to spray-dried lactose where the mechanism of compression 
by fragmentation of particles prevails (11). Values in Table II show that the values of all 
energies in tableting materials with both types of dry binders increase with increasing 
compression force, plasticity decreases due to a decreasing number of pores in the com-
pact, more markedly decreasing in the case of tableting materials with spray-dried lactose 
(Flowlac 100). Addition of glyceryl dibehenate to the tableting material with microcrystal-
line cellulose decreases the total energy of compression primarily due to a decrease in the 
precompression energy, because here it acts also as a lubricant, and due to the energy of 
plastic deformation; the energy of elastic deformation is not infl uenced. The total energy 
of compression of tableting materials with spray-dried lactose is not markedly infl uenced 
by addition of glyceryl dibehenate. Plasticity of tableting materials with both dry binders 
decreases due to addition of glyceryl dibehenate, more markedly than in the case of spray-
dried lactose.
Addition of glyceryl dibehenate exerts diff erent impacts on the strength of tablets in 
relation to the dry binder employed (Fig. 1). An increase in the concentration of glyceryl 
dibehenate to 15 % in the tableting material with microcrystalline cellulose causes a de-
crease in the strength of tablets; on the other hand, its increase to 20 % increases the 
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strength. This fact is connected with the initial decrease in the bonds of microcrystalline 
cellulose, a further increase in glyceryl dibehenate concentration compensating decreased 
binding ability (12). In the case of spray-dried lactose, it depends on compression force, 
because in the case of compression forces of 12 and 14 kN increasing concentration of 
glyceryl dibehenate does not infl uence the strength of tablets. Only at 16 kN there is a 
decrease in the strength of tablets due to addition of 20 % glyceryl dibehenate (13).
Evaluation of tablet dissolution
Active substance release from tablets was described by kinetic models, in which the 
amount of drug dissolved (At) is a function of the dissolution time t, At = f(t). To analyze 




(kN) Emax ± SD (J) E1 ± SD (J) E2 ± SD (J) E3 ± SD (J) PI ± SD (%)
MCC +
10 % C
  4  8.84 ± 0.14  5.31 ± 0.15 3.10 ± 0.02 0.43 ± 0.01 87.9 ± 0.2
  5 11.72 ± 0.53  7.38 ± 0.52 3.73 ± 0.04 0.61 ± 0.01 86.0 ± 0.2
  6 15.27 ± 0.32 10.18 ± 0.30 4.28 ± 0.04 0.81 ± 0.01 84.1 ± 0.2
MCC +
15 % C
  4  8.35 ± 0.14  5.23 ± 0.14 2.71 ± 0.02 0.42 ± 0.01 86.6 ± 0.2
  5 10.75 ± 0.30  6.92 ± 0.29 3.24 ± 0.03 0.60 ± 0.01 84.5 ± 0.2
  6 13.42 ± 0.37  8.93 ± 0.35 3.68 ± 0.04 0.81 ± 0.01 82.0 ± 0.2
MCC +
20 % C
  4  8.47 ± 0.14  5.34 ± 0.15 2.71 ± 0.02 0.42 ± 0.00 86.6 ± 0.1
  5 10.96 ± 0.20  7.17 ± 0.18 3.19 ± 0.03 0.60 ± 0.01 84.2 ± 0.2
  6 13.13 ± 0.39  8.73 ± 0.35 3.56 ±0.06 0.80 ± 0.01 81.7 ± 0.3
FL +
10 % C
12 18.21 ± 0.22 11.74 ± 0.23 3.78 ± 0.02 2.70 ± 0.01 58.3 ± 0.2
14 22.07 ± 0.37 14.22 ± 0.34 4.24 ± 0.07 3.61 ± 0.02 54.0 ± 0.3
16 26.05 ± 0.23 16.80 ± 0.26 4.68 ± 0.05 4.57 ± 0.02 50.6 ± 0.4
FL +
15 % C
12 18.59 ± 0.17 12.43 ± 0.18 3.40 ± 0.02 2.76 ± 0.02 55.2 ± 0.3
14 22.25 ± 0.35 14.80 ± 0.33 3.81 ± 0.08 3.65 ± 0.04 51.1 ± 0.3
16 26.14 ± 0.45 17.38 ± 0.42 4.13 ± 0.02 4.64 ± 0.03 47.1 ± 0.1
FL +
20 % C
12 18.64 ± 0.34 12.63 ± 0.33 3.21 ± 0.05 2.80 ± 0.02 53.5 ± 0.3
14 21.84 ± 0.18 14.64 ± 0.17 3.53 ± 0.03 3.67 ± 0.03 49.0 ± 0.2
16 25.60 ± 0.49 17.09 ± 0.48 3.83 ± 0.02 4.68 ± 0.02 45.0 ± 0.1
MCC – Microcel MC-102
C – Compritol 888 ATO
FL – Flowlac 100
CF – compression force
Emax – total energy
SD – standard deviation
E1 – energy of precompression
E2 – energy of plastic deformation
E3 – energy of elastic deformation
Pl – plasticity
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the dissolution profi les of tablets with the diff erent dry binders, the obtained experimental 
curves were fi  ed by the fi rst-order, Weibull (Fig. 2) and Higuchi models (14). Detailed 
regression and stat istical analysis of the eff ect of the employed dry binder on drug release 
was carried out. The coeffi  cient of determination (R2), residual sum of squares (RSS), 



















MCC+10% C MCC+15% C MCC+20% C FL+10% C FL+15% C FL+20% C
4 5 6 12 14 16
Fig. 1. Tensile strength of tablets as a function of compression force (mean ± SD, n = 10) (MCC – Mi-
crocel MC-102, C – Compritol 888 ATO, FL – Flowlac 100).
Fig. 2. Release of the active substance from investigated formulations fi  ed by the Weibull model 
(mean ± SD, n = 6) (MCC – Microcel MC-102, C – Compritol 888 ATO, FL – Flowlac 100).
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with standard deviation (k) and Higuchi dissolution constant (kH) were estimated based 
on non-linear regression analysis using the least-squares method (LSM). Results of the 
regression analysis of dissolution profi les (Table III) confi rm the highest tightness of fi t (the 
highest value of R2 and the lowest value of RSS) for the Weibull model. The shape para-
meter in the Weibull model (n) is lower than 1 for all the prepared dosage forms, which 
indicates a higher slope of the initial part of the dissolution curve in comparison with the 
1st-order exponential profi le. Order of the release process (corresponds to the shape param-
eter in the Weibull model) of the active substance from the investigated forms is in the 
range from 0.64 to 0.77, which proves that more factors aff ect the release rate. The release 
rate of the active substance decreases with increasing content of glyceryl dibehenate. Non-
linear regression analysis of the rate constant mean values (Table III) for the drug formula-
tion with the same content of glyceryl dibehenate showed that there were insignifi cant 
statistical diff erences between tablets with microcrystalline cellulose and spray-dried lac-
tose. Analysis of the amount of drug dissolved (mean values) showed insignifi cant diff er-
ences between tablets with microcrystalline cellulose and spray-dried lactose containing 
10 % of glyceryl dibehenate but more signifi cant diff erences for formulations with 15 and 
20 % of glyceryl dibehenate. As shown in Fig. 2, increasing content of glyceryl dibehenate 
in tablets with spray-dried lactose decreases the A∞ value. Formulations containing micro-
crystalline cellulose and 20 % of glyceryl dibehenate (MCC + 20 % C) show lower A∞ value 
in comparison with tablets containing 10 % of glycerol dibehenate (MCC + 10 % C). For 
tablets containing microcrystalline cellulose and 15 % of glyceryl dibehenate (MCC + 15 % 
C), an anomalous dissolution profi le (should be the subject of further research) was found.
Table III. Dissolution data by non-linear regression analysis
Tableting
material
1th order kinetic model
At = Aµ (1 – e–k t)
Weibull model
At = Aµ (1 – e–(k t)
n)
Higuchi model
At = kH Ö
–t
k ´ 103 (h–1)a R2 RSS k ´ 103 (h–n)a R2 RSS n R2 RSS
FL + 
10 % C 197.0 ± 7.7 0.9890 153.00 162.1 ± 6.1 0.9984 20.02 0.75 0.9372 549.43
FL + 
15 % C 140.5 ± 6.7 0.9875 141.69   85.6 ± 7.7 0.9985 15.55 0.71 0.9860 158.47
FL + 
20 % C 114.2 ± 9.0 0.9723 203.90   71.6 ± 7.1 0.9918 54.82 0.64 0.9921   58.41
MCC + 
10 % C 212.1 ± 1.2 0.9760 292.21 151.5 ± 5.9 0.9993   7.85 0.64 0.9456 661.96
MCC + 
15 % C 143.6 ± 7.7 0.9835 270.88   72.2 ± 5.6 0.9994   8.84 0.66 0.9881 195.96
MCC + 
20 % C 117.4 ± 5.5 0.9903   91.41     76.5 ± 12.0 0.9958 36.56 0.77 0.9889 104.19
 MCC – Microcel MC-102
C – Compritol 888 ATO
FL – Flowlac 100 
a Mean ± SD, n = 6.
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CONCLUSIONS
Glyceryl dibehenate infl uences compressibility of tableting materials with microcrys-
talline cellulose more than those with spray-dried lactose. Glyceryl dibehenate in tableting 
materials with microcrystalline cellulose decreases the total energy of compression while 
in a higher concentration it increases the strength of tablets. The release rate constant of 
salicylic acid from tablets is decreased with increasing concentrations of glyceryl dibe-
henate, but it is not signifi cantly diff erent within the range of contents of the dry binders 
used. Increasing the content of glyceryl dibehenate infl uences the A∞ value in all formula-
tions.
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